Medicine
Penciclovir 1% cream
Penciclovir 1% cream is a generic prescription medicine for topical use, made by 4 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20º to 25ºC (68º to 77ºF).
Key facts
- Active ingredient (INN)
- Penciclovir
- Brand
- Sold under the generic name
- Strength
- 1%
- Dosage form
- Cream
- Route
- Topical
- Packs
- 1 tube and 1 more
- Manufacturers
- Amneal Pharmaceuticals NYMylan PharmaceuticalsPadagis Israel PharmaceuticalsTeva Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20º to 25ºC (68º to 77ºF).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- D06BB06 Penciclovir
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 14 November 2022
- Identifiers
- RxCUI 312255DailyMed set ID 9118bbe9-8231-40c8-b11a-6c4a5f41aa16, 9cb88c28-d9c9-45e3-b4fe-083327f122de, 5d95b934-2ba6-41b9-928f-6d2ce12f93f5 +1NDC 69238-1791, 0378-0896, 0093-3186 +1Application ANDA214100, NDA020629, ANDA212710 +1
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 tube in 1 carton / 5 g in 1 tube | 69238-1791-7 | Amneal Pharmaceuticals NY | 25 August 2025 |
| 1 tube in 1 carton / 5 g in 1 tube | 0378-0896-55 | Mylan Pharmaceuticals | 16 November 2022 |
| 1 tube in 1 carton / 5 g in 1 tube | 45802-440-75 | Padagis Israel Pharmaceuticals | 7 November 2024 |
| 1 tube in 1 carton / 5 g in 1 tube | 0093-3186-20 | Teva Pharmaceuticals | 14 November 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 24 September 1996 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Penciclovir 1% cream.
Clinical summary
Penciclovir is a herpesvirus nucleoside analog DNA polymerase inhibitor indicated for the treatment of recurrent herpes labialis (cold sores) in adults and children 12 years of age or older. It is available as cream for topical use. MedsAcross supplies Penciclovir for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PenciclovirFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Penciclovir prescribing information (Mylan Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Penciclovir 1% cream for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.